Aidan Heller

Associate Scientist

Aidan Heller is pursuing a B.A. in Molecular and Cell Biology at UC Berkeley, where he conducted research in Professor Rebecca Heald's lab studying genome stability and cell division. He worked at Sandia National Laboratories on DoD-funded biodefense programs developing medical countermeasures against filoviruses and coronaviruses, and at Sanofi in Checkpoint Immunology supporting preclinical development of an antibody therapeutic for autoimmune indications. Aidan first joined Centivax as a Virology Intern and now serves as an Associate Scientist.